Our Patient identification Platform (Patient IP) enables the rapid, automated, identification of potential clinical study participants. The current clinical trials environment is ripe with challenges: while there have never been as many trial opportunities for patients, the criteria for inclusion has gotten incredibly individualized and as such, many trials fail on enrollment, retention and/or timeline fronts. This is precisely the problem that Patient IP was created to address. Patient IP utilizes multiple processes and patented algorithms to rapidly evaluate digital patient records data against specific trial criteria, displaying results visually, with accompanying analytics for further elucidation. While the fully HIPAA-compliant platform additionally has the power to improve research design, protocol modeling and feasibility testing, tremendous value lies in its adoption by savvy providers who seek deeper patient engagement and an active role in bringing new therapies to market.
Looking for a particular Patient identification Platform (Patient I.P.) employee's phone or email?
Patient identification Platform (Patient I.P.) Questions
The Patient identification Platform (Patient I.P.) annual revenue was $7 million in 2026.
Patient identification Platform (Patient I.P.) is based in Rochester, New York.
The NAICS codes for Patient identification Platform (Patient I.P.) are [517110, 51, 5171, 517, 51711].
The SIC codes for Patient identification Platform (Patient I.P.) are [7375, 73, 737].
Related Companies
